Using osteoporosis management to reduce fractures in elderly women

Nurse Practitioner

Volumn 24, Issue 3, 1999, Pages 26-49

  McClung, Betsy Love ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CALCITONIN; CALCIUM; PIPERIDINE DERIVATIVE; RALOXIFENE;

AGED; ESTROGEN THERAPY; EXERCISE; FALLING; FEMALE; FRACTURE; GERIATRIC ASSESSMENT; HUMAN; NUTRITION; PATIENT EDUCATION; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK FACTOR;

ACCIDENTAL FALLS; AGED; CALCITONIN; CALCIUM; ESTROGEN ANTAGONISTS; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; FRACTURES, BONE; GERIATRIC ASSESSMENT; HUMANS; NUTRITION PHYSIOLOGY; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT EDUCATION; PIPERIDINES; RALOXIFENE; RISK FACTORS;

EID: 0033090960     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/19996205-199903000-00004     Document Type: Article

References (38)

1. Consensus Developtnent Statement: Who are candidates for prevention and treatment for osteoporosis? Osteoporos Int 1997;7:1-6
2. Kanis JA, WHO Study Group: Assessmcnt of fracture risk and its applica-tion to screening for postmenopausal osteoporosis: Synopsis of a Wl IO re-port. Osteoporos Tnt 1994;4:369-81
3. Ross PD: Prediction of fracture risk. Part 2: Other risk factors. Am J Med
4. Sei 1996;312:260-69
5. Silver H, Einhorn TA: Osteoporosis and aging. Clin Orthop 1995;316:10-20
6. Looker AC, Orwoll ES, Johnston CC, et al.: Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 1997; 12:1761-68
7. iVIelton LJ: Epidemiology of age-related fractures. In: Avioli LV, ed: The Ostcoporotic Syndrome, 3rd ed., New York, NY: Wiley-Liss; 1993:17-38
8. Looker AC, Wasnich RO: Epidcmiology of low bonc mass and fractures. Am J Managed Carc 1996;2(suppl):55-59
9. Melton LJ: Epidcmiology of hip fractures: Implications of the expo-ncntial incrcasc with age. Bonc 1996;18(suppl 3): 121S-25S
10. Cummings SR, Black DM, Rubin SM: Lifctime risk of hip, Colles’ or vertebral fracture and coronary heart disease among whitc postmenopausal women. Arch Intern Med 1992;149:2445-48
11. Melton LJ, ClirischilJes EA, Cooper C, et al.: How many women ha ve osteoporosis?) IíoneMiner Res 1992;7:1005-10
12. Kiel DP: The approacli to osteoporosis in the elderly patient. In: Rosen CJ, ed: Osteoporosis: Diagnostic and Thcrapeudc Principies. Totowa, NJ: Humana Press 1996:225-38
13. Kleerckoper M, Nelson DA: Bone mineral density testing at the meno-pause and bcyond: An opinion. Menopause Manage 1998;7:21-24
14. Kleerckoper M, Nelson DA, Peterson EL, et al.: Outcomc variables in osteoporosis trials. Bone 1992;13(suppl 1):S29-S34
15. Allcn SM: Primary osteoporosis: Methods to conibat bonc loss that accom-panies aging. Postgrad Med 1993;93:43-55
16. Ettinger B, Gcnant HK, Cann CE: Long-term estrogen replacement ther-apy prevents bonc loss and fractures. Ann Intern Med 1985; 102(3):319-24
17. McCIung MR, McCIung BL: Osteoporosis. In: Rakel RE, ed: Conn’s Cur-rentTherapy. Philadclphia: WB Saunders Co.; 1997:581-87
18. Ettinger B, Gcnant K, Cann CE: Postmenopausal bone loss is prevented by treatment with Iow-dose estrogen with calcium. Ann Intern Med 1987; 106:40-45
19. Liberman UA, Weiss SR, Broli J, et al., and the Alendronate Phase II Osteoporosis Treatment Study Group: Effect of oral alendronate on bone mineral density and the incidencc of fractures in postmenopausal osteoporosis. N EnglJ Med 1995;333:1437-43
20. Cummings SR, Black DM, Thompson DE: Alendronate rcduces the risk of vertebral fractures in women without preexisting vertebral fractures: Rc-sults of the Fracture Intervention Trial. Prcsented at the 19th Annual Mceting of the American Socicty for Bonc and Mineral Research, Cincin-nati, Ohio, Sept. 10-14,1997
21. Stock JL, Baylink DJ, Chesnut C, et al.: Calcitonin nasal spray reduces the incidencc of new vertebral fractures in postmenopausal women: Thrce ycar interiin rcsults of the proof study [abstract]. J Bone Miner Rcs 1997. Pro-gram and Abstracts. Abstract 187, S149
22. Dclmas PD, Bjarnason NH, Mitlak BH, et al.: Effects of raloxifene on bone mineral density, scruni cholcstcrol conccntrations, and uterine cn-dometrium in postmenopausal women. N EnglJ Med 1997;337:1641-87
23. Ensrud K, Black D, Reckcr R, et al.: The effect of 2 and 3 years of ralox-ifene on vertebral and nonvcrtebral fractures in postmenopausal women with osteoporosis. Bone 1998;23(5S):Abstract 1105
24. Optimal Nutrition for Good Health: The Bcnefits of Nutritional Supplc-ments. Council for Responsiblc Nutrition. Washington, D.C. 1998
25. Riggs BL, Melton LJ: The prevention and treatment of osteoporosis. N EnglJ Med 1992;327:620-27
26. Chapuy MC, Arlot ME, Duboeuf F, etal.: Vitamin D3 and calcium to pre-vent hip fractures in elderly women. N EnglJ Med 1992;327:1637-42
27. Lamberg-AIlardt C: Is there a role for vitamin D in osteoporosis? Calcif Tissue Int 1991;49(suppl):S46-S49
28. Lips P, Graafnians WC, Ooms ME, et al.: Vitamin D supplcmcntation and fracture incidence in elderly persons. Ann Intern Med 1996;124:400-06
29. Haines ST, Caceras B, Yancey L: Alternatives to estrogen replacement therapy for preventing osteoporosis. J Am Pharm Assoe 1996;36:707-15
30. Brandi ML: Natural and synthctic isoflavones in the prevention and treatment of chronic diseases. Calcif Tissue Int 1997;61 (suppl):S5-S8
31. Chcstnut CM: Bone mass and exercise. AmJ Med 1993;95(suppl):34S-36S
32. McCIung MR: Nonpharmacologic manngcincnt of osteoporosis. In: Marcus R, ed: Osteoporosis. Oxford, England: Blackwell Scicntific Publi-cations 1994:336-53
33. Hayes WC, Meycrs ER: Biomechanics of fractures. In: Riggs BL, Melton LJ III, eds: Osteoporosis: Etiology, Diagnosis and Management, 2nd edi-tion. Philadclphia: Lippincott-Raven Pubs., 1995:93-114
34. Lauritzen JB, Petersen MM, Lund B: Effect of externai hip protcctors on hip fractures. Lancet 1993:341:11-13
35. Sinaki M: Musculoskeletal rchabilitation. In: Riggs BL, Melton LJ III, eds: Osteoporosis: Etiology, Diagnosis, and Management, 2nd edition. Philadclphia: Lippincott-Raven Pubs.; 1995:435-73
36. Gold DT: The Clinical impact of vertebral fractures: Quality of life in women with osteoporosis. Bone 1996; 18(3 suppl):185S-189S
37. Gold DT, Drezner MD: Quality of life. In: Riggs BL, Melton LJ III, eds: Osteoporosis: Etiology, Diagnosis, and Management, 2nd edition. Philadclphia: Lippincott-Raven Pubs.; 1995:475-80
38. McCIung BL, Overdorf JH: Psychosocial aspects of osteoporosis. In: Rosen CR, ed. Osteoporosis Diagnosis and Therapcutic Principies, Totowa, N.J.: Humana Press, 1996; 59-75